Cargando…
ASPM promotes glioblastoma growth by regulating G1 restriction point progression and Wnt-β-catenin signaling
Increasing evidence has indicated that the disorganized expression of certain genes promotes tumour progression. In this study, we elucidate the potential key differentially expressed genes (DEGs) between glioblastoma (GBM) and normal brain tissue by analysing three different mRNA expression profile...
Autores principales: | Chen, Xin, Huang, Lijie, Yang, Yang, Chen, Suhua, Sun, Jianjun, Ma, Changcheng, Xie, Jingcheng, Song, Yongmei, Yang, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6977704/ https://www.ncbi.nlm.nih.gov/pubmed/31905171 http://dx.doi.org/10.18632/aging.102612 |
Ejemplares similares
-
ASPM Promotes the Progression of Anaplastic Thyroid Carcinomas by Regulating the Wnt/β-Catenin Signaling Pathway
por: Jiang, Liang, et al.
Publicado: (2022) -
ASPM promotes hepatocellular carcinoma progression by activating Wnt/β‐catenin signaling through antagonizing autophagy‐mediated Dvl2 degradation
por: Zhang, Haifeng, et al.
Publicado: (2021) -
ASPM combined with KIF11 promotes the malignant progression of hepatocellular carcinoma via the Wnt/β-catenin signaling pathway
por: Wu, Bin, et al.
Publicado: (2021) -
PELP1 promotes glioblastoma progression by enhancing Wnt/β-catenin signaling
por: Sareddy, Gangadhara R, et al.
Publicado: (2019) -
The differential distributions of ASPM isoforms and their roles in Wnt signaling, cell cycle progression, and pancreatic cancer prognosis
por: Hsu, Chung‐Chi, et al.
Publicado: (2019)